Study finds almost half of patients withhold information in their EMR

Almost half of the patients who participated in a study withheld clinically sensitive information in their EHR from some or all of their healthcare providers.

The Regenstrief Institute, Indiana University School of Medicine and safety net provider Eskenazi Health partnered to design and conduct the "first real-world trial" intended to determine how much control patients should have over their health information and whether withholding it impacts their treatment. During the six-month trial, 105 patients in an Eskenazi Health primary care clinic were able to indicate preferences for which clinicians could access sensitive information in their EMR, such as information on sexually transmitted diseases, substance abuse or mental health, and designating what the clinicians could see.

Regenstrief informatics developers created a system where those preferences guided what information doctors, nurses and other clinic staff could see. Patients were able to hide some or all of their data from some or all providers. Almost half (49 percent) of the 105 patients who participated elected to withhold information contained in their medical record from some or all of their providers.

Patients strongly desired such control, while their providers had mixed reactions. Some providers were fine with it as long as patients knew that hiding information could adversely affect their care, and they were willing to take that risk. Other providers strongly objected to not being able to see all of the information in their patients’ records, not wanting to be responsible for bad or unsafe care.

The providers were able to override patients’ preferences and view any hidden data, if they felt the patient’s healthcare required it, by hitting a “break the glass” button on their computer screens. When providers hit this button, the program recorded the time, the patient whose electronic chart was being viewed and the data displayed.

"We learned that patients have widely different opinions of what kinds of their healthcare data they would like visible to different members of their healthcare team and others, such as health services researchers, who might have access to information in their electronic medical record," said Regenstrief President and CEO William Tierney, MD, principal investigator of the project.

The results of the trial are presented, interpreted and analyzed in five peer-reviewed research papers describing how the patient-controlled system was developed, how the trial was conducted and how patients and their providers felt about patient control; a point-counterpoint discussion; and commentaries that comprise the January 2015 supplement to the Journal of General Internal Medicine.

The work was supported in part by a $1.6 million grant from the Office of the National Coordinator for Health IT to the Indiana Health Information Technology Corp.

Access the study and related articles.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.